The civic record
Read. Follow. Verify.Kentucky Bill Allows Intranasal Epinephrine in Schools for Severe Allergies
Last action · January 14, 2026: to Health Services (H)Sponsors: Adrielle Camuel and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Kentucky HB 156 expands student access to severe allergy treatments by explicitly adding intranasal epinephrine devices to existing school medication rules, individual health plans, and liability protections.
Expands emergency allergy medication options for students by permitting intranasal epinephrine alongside traditional injectable devices in schools and school-sponsored activities.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Students with asthma or at risk of anaphylaxis
Students are permitted to possess and use intranasal epinephrine devices at school and school-sponsored activities.
School personnel
Authorized employees receive civil immunity from ordinary negligence when administering emergency epinephrine or rescue inhalers in good faith.
Kentucky Department for Public Health
The department is directed to develop clinical protocols for epinephrine and bronchodilator use in public health manuals.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What new type of medication is added to school policies under this bill?
Are schools required to purchase and store emergency epinephrine devices?
Are school employees protected from lawsuits if they administer emergency medication?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
2 actions- Jan 14, 2026HouseCommitteeto Health Services (H)
- Jan 7, 2026HouseIntroducedintroduced in House to Committee on Committees (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
apps.legislature.ky.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 45)
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
